Presentation AHA 2022 Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial Presenter: David E. Kandzari November 07, 2022
Presentation TCT 2022 Transcatheter Tricuspid Valve Replacement: Lessons Learned from Recent Clinical Trials Presenter: Neil Fam September 19, 2022
Presentation TCT 2022 Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial Presenter: Pablo Salinas September 19, 2022
Presentation TCT 2022 TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized… Presenter: Jonas Haener September 19, 2022
Presentation TCT 2022 Clinical Trial Data Supporting the Use of Tricuspid TEER in Symptomatic Severe TR Patients Presenter: Charles Davidson September 19, 2022
Presentation TCT 2022 Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial Presenter: Antonio Mangieri September 19, 2022
Presentation TCT 2022 Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial Presenter: Rania Hammami September 19, 2022
Presentation TCT 2022 Cardiogenic Shock Trials: Defining the Clinical Need and Framing the Issues Presenter: Navin Kapur September 19, 2022
Presentation TCT 2022 Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Presenter: Shamir Mehta September 19, 2022
Presentation TCT 2022 A Randomised Controlled Trial Assessing the Value of Computed Tomography Cardiac Angiography (CTCA) in Improving Patient Satisfaction and Reducing Contrast Load, Procedural Duration, and Complications in Patients Who Had Previous Bypass Operation (CABG)… Presenter: Daniel Jones September 19, 2022
Presentation TCT 2022 Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial Presenter: Jung-Min Ahn September 19, 2022
Presentation TCT 2022 What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE? Presenter: Eric Secemsky September 19, 2022
Presentation TCT 2022 TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial. Presenter: Tijn Jansen September 19, 2022
Presentation TCT 2022 TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan Presenter: Shinichiro Masuda September 19, 2022
Presentation TCT 2022 The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort Presenter: Charles J. Davidson September 19, 2022
Presentation TCT 2022 Clinical Trial Updates: A Selective Review of What All Operators Should Know Presenter: John Carroll September 18, 2022
Presentation TCT 2022 Clinical Implications of RADIANCE II and Recent Renal Denervation Trials: A Clinician’s Perspective Presenter: Patrick O'Gara September 18, 2022
Presentation TCT 2022 Transformative Changes in Clinical Research: A Futurist’s Viewpoint Presenter: C. Michael Gibson September 18, 2022
Presentation TCT 2022 TCT 7: Invasive Versus Conservative Strategy in Elderly Patients With Non-ST Elevation Myocardial Infarction: A Meta-analysis of Randomized Controlled Trials Presenter: Mahmoud Khalil September 18, 2022
Presentation TCT 2022 Health Equity Issues in Clinical Trials: Can We Accelerate Progress? Presenter: Clyde Yancy September 18, 2022